Nucera, Eleonora
 Distribuzione geografica
Continente #
NA - Nord America 10.904
EU - Europa 8.229
AS - Asia 6.729
SA - Sud America 1.341
Continente sconosciuto - Info sul continente non disponibili 267
AF - Africa 149
OC - Oceania 24
AN - Antartide 1
Totale 27.644
Nazione #
US - Stati Uniti d'America 10.596
SG - Singapore 3.139
DE - Germania 2.937
CN - Cina 1.539
SE - Svezia 1.106
IT - Italia 1.087
BR - Brasile 1.049
UA - Ucraina 656
FR - Francia 645
VN - Vietnam 563
GB - Regno Unito 361
IN - India 337
PL - Polonia 334
IE - Irlanda 302
FI - Finlandia 232
ID - Indonesia 225
JP - Giappone 181
CA - Canada 144
RU - Federazione Russa 141
HK - Hong Kong 137
AR - Argentina 106
BD - Bangladesh 100
TR - Turchia 90
MX - Messico 86
NL - Olanda 85
IQ - Iraq 71
ES - Italia 68
BE - Belgio 49
IR - Iran 44
CO - Colombia 41
CZ - Repubblica Ceca 41
ZA - Sudafrica 40
AT - Austria 39
EC - Ecuador 37
SA - Arabia Saudita 35
VE - Venezuela 35
PK - Pakistan 30
MA - Marocco 24
PH - Filippine 24
CL - Cile 23
AE - Emirati Arabi Uniti 21
JM - Giamaica 21
KR - Corea 21
UZ - Uzbekistan 21
AU - Australia 20
KZ - Kazakistan 17
LT - Lituania 17
RO - Romania 17
JO - Giordania 16
PY - Paraguay 16
AL - Albania 15
IL - Israele 14
MY - Malesia 14
NP - Nepal 14
CH - Svizzera 13
AZ - Azerbaigian 12
EG - Egitto 12
KE - Kenya 11
PT - Portogallo 11
UY - Uruguay 11
BO - Bolivia 10
PE - Perù 10
BG - Bulgaria 9
CI - Costa d'Avorio 9
DZ - Algeria 9
ET - Etiopia 9
TH - Thailandia 9
TN - Tunisia 9
CR - Costa Rica 8
NO - Norvegia 8
BB - Barbados 7
GR - Grecia 7
PA - Panama 7
DK - Danimarca 6
GT - Guatemala 6
HN - Honduras 6
KG - Kirghizistan 6
OM - Oman 6
RS - Serbia 6
TT - Trinidad e Tobago 6
BH - Bahrain 5
HU - Ungheria 5
LV - Lettonia 5
QA - Qatar 5
TW - Taiwan 5
AO - Angola 4
DO - Repubblica Dominicana 4
LB - Libano 4
LU - Lussemburgo 4
MK - Macedonia 4
MM - Myanmar 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
SY - Repubblica araba siriana 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
EE - Estonia 3
EU - Europa 3
LK - Sri Lanka 3
Totale 27.326
Città #
Singapore 1.731
Chandler 1.357
Ashburn 1.181
San Jose 815
Dallas 357
Jacksonville 327
Dublin 299
Warsaw 296
San Mateo 292
Beijing 283
Milan 229
Ann Arbor 225
Wilmington 218
Los Angeles 210
Woodbridge 198
New York 196
Jakarta 186
Ho Chi Minh City 179
Lauterbourg 177
Nanjing 171
The Dalles 171
Nürnberg 167
Fairfield 166
Tokyo 152
Frankfurt am Main 142
Hanoi 136
Dearborn 132
Munich 128
Rome 122
Hong Kong 118
Nanchang 117
Redwood City 113
Seattle 110
Hefei 106
Lawrence 106
Houston 105
Boston 98
Marseille 97
São Paulo 89
Moscow 87
Bremen 83
Helsinki 79
Chicago 72
Buffalo 70
Santa Clara 67
Council Bluffs 63
Princeton 60
Boardman 58
Cambridge 57
Shenyang 53
University Park 50
London 48
Brussels 44
Leawood 44
Brooklyn 43
Paris 43
Atlanta 38
Hebei 38
Pune 38
Toronto 37
Izmir 36
Orem 36
San Francisco 36
Phoenix 35
Amsterdam 33
Changsha 32
Da Nang 32
Norwalk 32
Nuremberg 32
Shanghai 32
Stockholm 32
Brno 31
Hangzhou 31
Lancaster 31
Fremont 30
Cattolica 28
Denver 28
Guangzhou 27
Mountain View 27
Montreal 26
St Louis 25
Zhengzhou 25
Baghdad 24
Kunming 24
Augusta 23
Düsseldorf 23
Jiaxing 23
Mexico City 23
Wroclaw 23
Simi Valley 22
Ankara 21
Dhaka 21
Falls Church 21
Kent 21
Rio de Janeiro 21
Belo Horizonte 20
Memphis 20
Chennai 19
Johannesburg 19
Madrid 19
Totale 13.538
Nome #
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study. 486
Successful tolerance induction to spiramycin in pregnancy 365
Latex Allergy: Current Status and Future Perspectives 360
Latex immunotherapy: evidence of effectiveness. 336
Clinical usefulness of patch and challenge tests in the diagnosis of cell-mediated allergy to betalactams 335
Eosinophilic oesophagitis (in nickel-allergic patient) regressed after nickel oral desensitization: A case report 310
Specific oral immunotherapy in food allergic patients: transient or persistent tolerance? 286
Prevalence of latex allergy in spina bifida: genetic and environmental risk factors. 273
Anaphylaxis by antihistamine containing bovine gelatin: the utility of the basophil activation test in the diagnostic work-up. 269
Latex Sensitisation and Allergy in Children with Myelomeningocele 262
Irritable bowel syndrome and nickel allergy: What is the role of the low nickel diet? 254
Allergy and psychologic evaluations of patients with multiple drug intolerance syndrome 246
Wheat desensitization treatment in patients with gluten sensitivity 244
Gene expression profiling of patients with latex and/or vegetable food allergy 243
A clinical trial of oral hyposensitization in systemic allergy to nickel 242
food allergy and food intolerance: diagnosis and treatment 233
Allergie e intolleranze alimentari 224
lezioni di immunoallergologia 221
Multiple-drug intolerance syndrome: clinical findings and usefulness of challenge tests 219
The clinical meaning of positive latex sIgE in patients with food/pollen adverse reactions 218
Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A "Real-Life" Observational Study in the First Year of Treatment 210
Delayed allergy to aminopenicillins: clinical and immunological findings 206
Anaphylactic Reactions During Cesarean Section 199
Allergic and non-allergic drug hypersensitivity reactions in children. 198
Diet intervention study through telemedicine assistance for systemic nickel allergy syndrome patients during the covid-19 pandemic 198
Amphotericin B and Lysine Acetylsalicylate in the Combined Treatment of Nasal Polyposis Associated with Mycotic Infection 191
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study 191
Latex sensitization: a special risk for the obstetric population? 190
-Idiopathic chronic urticaria and celiac disease 190
Profilin desensitization: A case series 188
The clinical meaning of positive latex sIgE in patients with food/pollen adverse reactions 188
Cross-reactivity and tolerability of cephalosporins in patients with cell-mediated allergy to penicillins. 187
Oral Specific Desensitization in Food-Allergic Children 187
Sublingual immunotherapy with natural rubber latex: a case report with 8-year follow-up 187
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 183
Utility of Basophil Activation Test for monitoring the acquisition of clinical tolerance after oral desensitization to cow's milk: Pilot study 181
A case of IgE-mediated allergy and cell-mediated allergy to Seaprose-S in the same patient 180
Oral rush desensitization in peanut allergy: a case report 180
Cross-reactivity and tolerability of Ertapenem in patients with IgE-mediated hypersensitivity to β-lactams 180
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 179
Delayed hypersensitivity to heparin in a patient with cancer: fondaparinux may be safe but needs to be tested 178
Idiopathic chronic urticaria and celiac disease 178
Sublingual immunotherapy for latex allergy: tolerability and safety profile of rush build-up phase 177
Hypersensitivity to major panallergens in a population of 120 patients 177
Peanut allergy in Italy: A unique Italian perspective 174
Interleukin-6 in Rheumatoid Arthritis 173
Clinical and quality of life assessment in patients with latex allergy during COVID-19 pandemic: Possible protective role of continuous latex immunotherapy 173
Delayed-type hypersensitivity to fenofibrate 172
Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria 172
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy 172
Therapeutic Strategies to Prevent the Recurrence of Nasal Polyps after Surgical Treatment: An Update and In Vitro Study on Growth Inhibition of Fibroblasts 172
Tolerability of aztreonam in patients with IgE-mediated hypersensitivity to beta-lactams 170
Detection of Gibberellin-Regulated Protein (Peamaclein) Sensitization among Italian Cypress Pollen-Sensitized Patients 170
Tolerability of aztreonam in patients with cell-mediated allergy to beta-lactams. 169
House dust mite allergy in Italy. Diagnostic and clinical relevance of Der p 23 (and of minor allergens): A real life, multicenter study 168
Positive patch tests to Euro coins in nickel-sensitized patients 167
Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria 165
Challenge tests in the diagnosis of latex allergy 164
A case of type IV hypersensitivity to topiramate and carbamazepine 164
Reazioni allergiche in odontoiatria 162
Apple desensitization in two patients with PR-10 proteins allergy 161
Successful fluorescein desensitization 161
Oral desensitisation in cow milk allergy: immunological findings 161
Positive allergological tests may turn negative with no further exposure to the specific allergen: a long-term, prospective, follow-up study in patients allergic to penicillin 160
Occupational contact dermatitis from carbapenems 159
Mometasone Furoate in Non-Allergic Rhinitis: A Real-Life Italian Study 156
The aspirin disease 156
Oral rush desensitization with tomato: a case report 156
Profilin desensitization in two patients with plant-derived food allergy 155
An Attempt of Specific Desensitizing Treatment with Gliadin in Coleliac Disease 154
Impact of nickel oral hyposensitization on quality of life in systemic nickel allergy syndrome 154
Latex allergy desensitization by exposure protocol: five case reports 153
A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab 153
Nasal lavage cytometry in the diagnosis of nonallergic rhinitis with eosinophilia syndrome (NARES) 152
Eosinophilic Esophagitis During Latex Desensitization 152
Sublingual desensitization in children with congenital malformations and latex allergy 150
Demonstration of an IgE-mediated immunological pathogenesis of a severe adverse reaction to gadopentetate dimeglumine 149
The importance of complying with vaccination protocols in developed countries: "anti-vax" hysteria and the spread of severe preventable diseases 148
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS 148
Sublingual desensitization in patients with wasp venom allergy: preliminary results 147
Sublingual-oral rush desensitization to mixed cow and sheep milk: a case report 147
Immunological aspects of oral desensitization in food allergy 147
Oral specific hyposensitization in the management of patients allergic to food 146
Specific ultrarush desensitization in Hymenoptera venom-allergic patients 146
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 146
Allergic reactions to midazolam: A case series from an Italian allergy unit 146
Oral desensitizing treatment in food allergy: clinical and immunological results 145
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy. 145
Successful desensitization of a child with desferrioxamine hypersensitivity 144
cross-reactivity and tolerability of imipenem in patients with delayed-type, cell-mediated hypersensitivity to beta-lactams 143
Latex rush desensitization. 142
Hypersensitivity to racecadotril: a case report 142
A case of cutaneous delayed-type allergy to oral dexamethasone and to betamethasone. 141
New protocol for desensitization to wheat allergy in a single case 140
Desensitization to thalidomide in a patient with multiple myeloma 140
Desensitization to co-trimoxazole in a patient with fixed drug eruption 140
Nickel allergy in lipid transfer protein sensitized patients: Prevalence and clinical features 139
Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy. 138
Doctor, can I desensitize my food-allergic child using directly the allergenic molecules? 138
The role of immune serological parameters and allergological tests in psoriasis 136
Totale 18.772
Categoria #
all - tutte 107.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.502


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.264 0 0 34 86 92 56 39 254 55 119 266 263
2022/20233.537 498 492 268 612 215 418 160 243 415 50 112 54
2023/20241.726 84 466 40 94 71 297 92 79 37 65 211 190
2024/20253.486 126 141 282 104 285 104 70 185 520 307 820 542
2025/20268.607 1.261 240 772 771 1.481 476 1.497 484 580 589 255 201
2026/20271.432 383 715 334 0 0 0 0 0 0 0 0 0
Totale 27.644